212 related articles for article (PubMed ID: 18600080)
21. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience.
Wissa I; Ebeid E; El-Shawarby S; Chandakas S; Kamal T; Hill N
J Obstet Gynaecol; 2009 Jan; 29(1):21-4. PubMed ID: 19280490
[TBL] [Abstract][Full Text] [Related]
22. The use of recombinant activated factor VII in congenital and acquired von Willebrand disease.
Franchini M; Veneri D; Lippi G
Blood Coagul Fibrinolysis; 2006 Nov; 17(8):615-9. PubMed ID: 17102646
[TBL] [Abstract][Full Text] [Related]
23. Coagulation problems in liver disease.
Rapaport SI
Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S69-74. PubMed ID: 10850568
[TBL] [Abstract][Full Text] [Related]
24. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.
Bosch J; Thabut D; Albillos A; Carbonell N; Spicak J; Massard J; D'Amico G; Lebrec D; de Franchis R; Fabricius S; Cai Y; Bendtsen F;
Hepatology; 2008 May; 47(5):1604-14. PubMed ID: 18393319
[TBL] [Abstract][Full Text] [Related]
25. Recombinant factor VIIa. An update on its clinical use.
Franchini M; Zaffanello M; Veneri D
Thromb Haemost; 2005 Jun; 93(6):1027-35. PubMed ID: 15968384
[TBL] [Abstract][Full Text] [Related]
26. The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
Schreiber MA; Holcomb JB; Hedner U; Brundage SI; Macaitis JM; Hoots K
J Trauma; 2002 Aug; 53(2):252-7; discussion 257-9. PubMed ID: 12169930
[TBL] [Abstract][Full Text] [Related]
27. Combined fresh frozen plasma with recombinant factor VIIa in restoring hemostasis for invasive procedures in children with liver diseases.
Chuansumrit A; Treepongkaruna S; Phuapradit P
Thromb Haemost; 2001 Apr; 85(4):748-9. PubMed ID: 11341519
[No Abstract] [Full Text] [Related]
28. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
29. Recombinant factor VIIa: a universal hemostatic agent?
Lloyd JV; Joist JH
Curr Hematol Rep; 2002 Sep; 1(1):19-26. PubMed ID: 12901121
[TBL] [Abstract][Full Text] [Related]
30. Recombinant activated factor VII as a universal haemostatic agent.
Hedner U
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S147-52. PubMed ID: 9819047
[TBL] [Abstract][Full Text] [Related]
31. [The use of recombinant activated factor VII in a patient with uncontrolled bleeding from the gastrointestinal tract].
Vitković R; Petrović I
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():246-8. PubMed ID: 19562877
[TBL] [Abstract][Full Text] [Related]
32. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
33. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
34. The emerging role of recombinant-activated factor VII in neurocritical care.
Fewel ME; Park P
Neurocrit Care; 2004; 1(1):19-29. PubMed ID: 16174895
[TBL] [Abstract][Full Text] [Related]
35. Hemostatic agents for bleeding: recombinant-activated factor VII and beyond.
Franchini M; Crestani S; Frattini F; Sissa C; Bonfanti C
Semin Thromb Hemost; 2015 Apr; 41(3):342-7. PubMed ID: 24937097
[TBL] [Abstract][Full Text] [Related]
36. Special report: recombinant activated factor VII for uncontrolled bleeding in non-hemophiliac patients.
Technol Eval Cent Assess Program Exec Summ; 2006 Oct; 21(10):1-2. PubMed ID: 17061400
[No Abstract] [Full Text] [Related]
37. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group.
Poon MC; d'Oiron R
Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S55-68. PubMed ID: 10850567
[TBL] [Abstract][Full Text] [Related]
38. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
Mindikoglu AL; Anantharaju A; George M; Leone N; Bejna J; Van Thiel DH
Hepatogastroenterology; 2003; 50(53):1697-9. PubMed ID: 14571820
[TBL] [Abstract][Full Text] [Related]
39. Synthetic factor VIIa concentrate to treat coagulopathy and gastrointestinal bleeding in an infant with end-stage liver disease.
Tobias JD; Berkenbosch JW
Clin Pediatr (Phila); 2002 Oct; 41(8):613-6. PubMed ID: 12403380
[No Abstract] [Full Text] [Related]
40. Challenges in the therapeutic use of a "so-called" universal hemostatic agent: recombinant factor VIIa.
Hoots WK
Hematology Am Soc Hematol Educ Program; 2006; ():426-31. PubMed ID: 17124094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
